Most Read News

The QIP news had initially propelled the stock to a record high in the previous session, but profit booking led to a decline by the end of the day.

The Memorandum of Understanding (MoU) between NLC India Limited and Rajasthan Urja Vikas Nigam Ltd (RVUNL) signifies a substantial investment exceeding ₹7000 Crore.

The projects are estimated to have a total cost of ₹410 Crore and ₹888 Crore, respectively.

The Election Commission is directed to publish the shared information by SBI by 5 PM on March 15. The bank's chairman must file an affidavit post-disclosure, with a warning of contempt if the order is not adhered to.

Additionally, HG Infra Engineering won a project for an Access Controlled Highway in Andhra Pradesh, covering a 4-lane section with paved shoulders from TN/AP Border to Puttur and a 6-lane section from Mallavaram to Renigunta, with a project cost of ₹862.11 Crore and a construction period of 24 months.

The IPO is entirely an Offer for Sale (OFS) of equity shares by promoters and existing shareholders, including Bipinbhai Vithalbhai Hadvani, Gopal Agriproducts Private Ltd, and Harsh Sureshkumar Shah.

As of the latest update, Alembic Pharma's shares were trading at ₹989.65 on the NSE, having delivered a return of approximately 29% in the past three months, driven by a strong Q3 performance.

Foreign institutional investors (FIIs) made a net purchase of shares amounting to ₹7,304.11 Crore, while domestic institutional investors (DIIs) bought ₹2,601.81 Crore worth of stocks on March 7, according to provisional data from the NSE.

The stock has witnessed a remarkable year-to-date increase of over 30%, outperforming the benchmark Sensex, which rose by 0.9% during the same period.

The proportion of investment in underlying funds/ETFs will be determined based on the discretion of the fund manager of the Scheme considering prevailing market conditions, and the macroeconomic environment.